Your browser doesn't support javascript.
loading
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway.
Chen, Cheng; Cheng, Chuan-Dong; Wu, Hong; Wang, Zuo-Wei; Wang, Li; Jiang, Zong-Ru; Wang, Ao-Li; Hu, Chen; Dong, Yong-Fei; Niu, Wan-Xiang; Qi, Shuang; Qi, Zi-Ping; Liu, Jing; Wang, Wen-Chao; Niu, Chao-Shi; Liu, Qing-Song.
Afiliación
  • Chen C; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Cheng CD; University of Science and Technology of China, Hefei, 230036, China.
  • Wu H; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Wang ZW; University of Science and Technology of China, Hefei, 230036, China.
  • Wang L; Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230036, China.
  • Jiang ZR; Anhui Province Key Laboratory of Brain Function and Brain Disease, Hefei, 230031, China.
  • Wang AL; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Hu C; Precision Medicine Research Laboratory of Anhui Province, Hefei, 230088, China.
  • Dong YF; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Niu WX; University of Science and Technology of China, Hefei, 230036, China.
  • Qi S; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Qi ZP; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Liu J; Precision Medicine Research Laboratory of Anhui Province, Hefei, 230088, China.
  • Wang WC; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
  • Niu CS; Precision Medicine Research Laboratory of Anhui Province, Hefei, 230088, China.
  • Liu QS; High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China.
Acta Pharmacol Sin ; 42(1): 108-114, 2021 Jan.
Article en En | MEDLINE | ID: mdl-32398685

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acrilamidas / Glioblastoma / Sistema de Señalización de MAP Quinasas / Inhibidores de Proteínas Quinasas / Compuestos de Anilina / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Animals / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acrilamidas / Glioblastoma / Sistema de Señalización de MAP Quinasas / Inhibidores de Proteínas Quinasas / Compuestos de Anilina / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Animals / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos